Primary Care

In this interview, Arwen Podesta, MD, DFAPA, DFASAM, describes how alcohol use disorder remains a significant burden for patients and the health care system, and that clinicians across specialties should...

A randomized crossover trial examined whether N-of-1 deprescribing trials could identify older men receiving little symptomatic benefit from chronic tamsulosin therapy.

Intismeran autogene plus pembrolizumab met the primary recurrence-free survival and a key secondary distant metastasis-free survival endpoint in the phase 3 INTerpath-001 trial in patients with completely...

In their Practical Updates in Primary Care session, Jeanne M. Ferrante, MD, MPH, and Nell Maloney Patel, MD, FACS, FASCRS, discussed evidence-based cancer screening updates for primary care, with emphasis...

In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...

Primary care physicians can help identify previously unrecognized hemophilia B, respond appropriately to bleeding and procedural risks, reinforce hematology-directed treatment plans, and support patients...

The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.

Primary care physicians can play a critical role in recognizing transthyretin amyloid cardiomyopathy, initiating an appropriate diagnostic evaluation, coordinating treatment, and helping patients and...

The FDA approved atacicept-vymj (Trutakna) to reduce proteinuria in adults with primary IgA nephropathy at risk for progression.

July 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...